Evidence map›Paper›PMID 34161263›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas.

Emmanuela N Bonglack, Joshua E Messinger, Jana M Cable, James Ch'ng, K Mark Parnell, Nicolás M Reinoso-Vizcaíno, Ashley P Barry, Veronica S Russell, Sandeep S Dave, Heather R Christofk and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 59 citations in OpenAlex.

  1. A guide to B cell metabolism.Nature reviews. Immunology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  15. Review
  16. Article
  17. Lactate and lactylation in cancer.Signal transduction and targeted therapy · 2025
    Review
  18. Article
  19. Review
  20. Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Emmanuela N BonglackDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710.ORCID 0000-0003-0800-1078
Joshua E MessingerDepartment of Molecular Genetics and Microbiology, Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710.
Jana M CableDepartment of Molecular Genetics and Microbiology, Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710.
James Ch'ngDepartment of Pediatrics, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095.ORCID 0000-0002-1028-1454
K Mark ParnellVettore, LLC, San Francisco, CA 94158.
Nicolás M Reinoso-VizcaínoDepartment of Molecular Genetics and Microbiology, Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710.ORCID 0000-0002-9769-3768
Ashley P BarryDepartment of Molecular Genetics and Microbiology, Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710.ORCID 0000-0002-2158-1516
Veronica S RussellDuke Center for Genomic and Computational Biology, Duke University Medical Center, Durham, NC 27710.ORCID 0000-0001-5268-4545
Sandeep S DaveDuke Center for Genomic and Computational Biology, Duke University Medical Center, Durham, NC 27710.
Heather R ChristofkDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095.ORCID 0000-0002-8662-4425
Micah A LuftigDepartment of Molecular Genetics and Microbiology, Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710; micah.luftig@duke.edu.ORCID 0000-0002-2964-1907
Duke University · USDuke Medical Center · USUniversity of California, Los Angeles · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
Pharmacological Sciences Training ProgramT32GM007105 · NIGMS · DUKE UNIVERSITY · PI KUHN, CYNTHIA M · 1985 to 2019
$9.0M
Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformationR01CA140337 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH ALAN · 2011 to 2025
$5.9M
Nutrient Regulation of Cancer Cell GrowthR01CA215185 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Heather Christofk · 2018 to 2026
$4.3M
Computational Biology and Bioinformatics Training ProgramT32GM071340 · NIGMS · DUKE UNIVERSITY · PI MAGWENE, PAUL MITAARI · 2005 to 2020
$3.3M
Metabolic Control of Hair Follicle Stem Cell Homeostasis and TumorigenesisR01AR070245 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHRISTOFK, HEATHER, LOWRY, WILLIAM E · 2018 to 2022
$2.1M
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte TumorigenesisF31CA257621 · NCI · DUKE UNIVERSITY · PI BONGLACK, EMMANUELA · 2021 to 2022
$52k
NCI NIH HHS F31 CA257621NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA140337NCI NIH HHS R01 CA215185NCI NIH HHS T32 CA009056NCI NIH HHS T32 CA009111NIAMS NIH HHS R01 AR070245NIGMS NIH HHS T32 GM007105NIGMS NIH HHS T32 GM071340
6 · The paper itself

Abstract

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that typically causes asymptomatic infection but can promote B lymphoid tumors in the immune suppressed. In vitro, EBV infection of primary B cells stimulates glycolysis during immortalization into lymphoblastoid cell lines (LCLs). Lactate export during glycolysis is crucial for continued proliferation of many cancer cells-part of a phenomenon known as the "Warburg effect"- and is mediated by monocarboxylate transporters (MCTs). However, the role of MCTs has yet to be studied in EBV-associated malignancies, which display Warburg-like metabolism in vitro. Here, we show that EBV infection of B lymphocytes directly promotes temporal induction of MCT1 and MCT4 through the viral proteins EBNA2 and LMP1, respectively. Functionally, MCT1 was required for early B cell proliferation, and MCT4 up-regulation promoted acquired resistance to MCT1 antagonism in LCLs. However, dual MCT1/4 inhibition led to LCL growth arrest and lactate buildup. Metabolic profiling in LCLs revealed significantly reduced oxygen consumption rates (OCRs) and NAD+/NADH ratios, contrary to previous observations of increased OCR and unaltered NAD+/NADH ratios in MCT1/4-inhibited cancer cells. Furthermore, U-

Indexed as

B-LymphocytesCell Line, TumorCell ProliferationEpstein-Barr Virus InfectionsGlucoseGlutathioneHerpesvirus 4, HumanHerpesvirus 8, HumanHumansLactic AcidLymphomaMetforminMonocarboxylic Acid TransportersNADOxygen ConsumptionPhenforminGlucoseGlutathioneLactic AcidMetforminMonocarboxylic Acid TransportersNADPhenforminReactive Oxygen Speciescancer metabolismEpstein–Barr viruslactate exportmonocarboxylate transporterviral lymphoma

Identifiers

PMID34161263
PMCPMC8237662
OpenAlexW3166813806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.